Rascol O - Search Results

1

The management of patients with early Parkinson's disease.

Rascol O, Payoux P, Ferreira J, Brefel-Courbon C. Rascol O, et al. Parkinsonism Relat Disord. 2002 Oct;9(1):61-7. doi: 10.1016/s1353-8020(02)00045-7. Parkinsonism Relat Disord. 2002. PMID: 12217623 Review.

2

Moving towards home-based community-centred integrated care in Parkinson's disease.

Fabbri M, Caldas AC, Ramos JB, Sanchez-Ferro Á, Antonini A, Růžička E, Lynch T, Rascol O, Grimes D, Eggers C, Mestre TA, Ferreira JJ. Fabbri M, et al. Among authors: rascol o. Parkinsonism Relat Disord. 2020 Sep;78:21-26. doi: 10.1016/j.parkreldis.2020.07.001. Epub 2020 Jul 7. Parkinsonism Relat Disord. 2020. PMID: 32674024 Review.

3

Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.

Thalamas C, Taylor A, Brefel-Courbon C, Eagle S, Fitzpatrick K, Rascol O. Thalamas C, et al. Among authors: rascol o. Eur J Clin Pharmacol. 1999 Jun;55(4):299-303. doi: 10.1007/s002280050632. Eur J Clin Pharmacol. 1999. PMID: 10424323 Clinical Trial.

4

Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.

Ferreira JJ, Rascol O. Ferreira JJ, et al. Among authors: rascol o. Curr Opin Neurol. 2000 Aug;13(4):431-6. doi: 10.1097/00019052-200008000-00011. Curr Opin Neurol. 2000. PMID: 10970061 Review.

5

Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.

Montastruc JL, Desboeuf K, Lapeyre-Mestre M, Senard JM, Rascol O, Brefel-Courbon C. Montastruc JL, et al. Among authors: rascol o. Mov Disord. 2001 May;16(3):511-4. doi: 10.1002/mds.1093. Mov Disord. 2001. PMID: 11391747 Clinical Trial.

6

Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.

Rascol O, Arnulf I, Peyro-Saint Paul H, Brefel-Courbon C, Vidailhet M, Thalamas C, Bonnet AM, Descombes S, Bejjani B, Fabre N, Montastruc JL, Agid Y. Rascol O, et al. Mov Disord. 2001 Jul;16(4):708-13. doi: 10.1002/mds.1143. Mov Disord. 2001. PMID: 11481696 Clinical Trial.

7

Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.

Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL. Senard JM, et al. Among authors: rascol o. Drugs Aging. 2001;18(7):495-505. doi: 10.2165/00002512-200118070-00003. Drugs Aging. 2001. PMID: 11482743 Review.

8

[Management of levodopa-induced dyskinesia].

Rascol O, Ferreira JJ, Payoux P, Brefel-Courbon Ch, Montastruc JL. Rascol O, et al. Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S117-24. Rev Neurol (Paris). 2002. PMID: 12690671 Review. French.

9

Abnormal pain perception in patients with Multiple System Atrophy.

Ory-Magne F, Pellaprat J, Harroch E, Galitzsky M, Rousseau V, Pavy-Le Traon A, Rascol O, Gerdelat A, Brefel-Courbon C. Ory-Magne F, et al. Among authors: rascol o. Parkinsonism Relat Disord. 2018 Mar;48:28-33. doi: 10.1016/j.parkreldis.2017.12.001. Epub 2017 Dec 8. Parkinsonism Relat Disord. 2018. PMID: 29254664

10

[Parkinson "plus"].

Fabre N, Brefel-Courbon C, Rascol O. Fabre N, et al. Among authors: rascol o. Rev Prat. 1997 May 15;47(10):1077-82. Rev Prat. 1997. PMID: 9208670 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

588 results

Search Page